Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Imbalance of immunological synapse-kinapse states reflects tumor escape to immunity in glioblastoma
Laura R. Díaz, … , Carlos Barcia Sr., Carlos Barcia Jr.
Laura R. Díaz, … , Carlos Barcia Sr., Carlos Barcia Jr.
Published September 20, 2018
Citation Information: JCI Insight. 2018;3(18):e120757. https://doi.org/10.1172/jci.insight.120757.
View: Text | PDF
Resource and Technical Advance Immunology

Imbalance of immunological synapse-kinapse states reflects tumor escape to immunity in glioblastoma

  • Text
  • PDF
Abstract

Since the proper activation of T cells requires the physical interaction with target cells through the formation of immunological synapses (IS), an alteration at this level could be a reason why tumors escape the immune response. As part of their life cycle, it is thought that T cells alternate between a static phase, the IS, and a dynamic phase, the immunological kinapse (IK), depending on high or low antigen sensing. Our investigation performed in tissue samples of human glioma shows that T cells are able to establish synapsing interactions not only with glioma tumorigenic cells, but also with stromal myeloid cells. Particularly, the IS displaying a T cell receptor–rich (TCR-rich) central supramolecular activation cluster (cSMAC) is preferentially established with stromal cells, as opposed to malignant cells. Conversely, T cells in the malignant areas showed distinct morphometric parameters compared with nonneoplastic tissue — the former characterized by an elongated shape, well-suited to kinaptic dynamics. Importantly, high-resolution 3-dimensional analyses demonstrated the existence of bona-fide IK preferentially arranged in malignant areas of the tumor. This imbalance of IS/IK states between these 2 microenvironments reveals the low antigenic sensing of T cells when patrolling tumorigenic cells and reflects the immunoevasive environment of the tumor.

Authors

Laura R. Díaz, Elena Saavedra-López, Leire Romarate, Izaskun Mitxitorena, Paola V. Casanova, George P. Cribaro, José M. Gallego, Ana Pérez-Vallés, Jerónimo Forteza-Vila, Clara Alfaro-Cervello, José M. García-Verdugo, Carlos Barcia Sr., Carlos Barcia Jr.

×

Figure 7

Presence of T cells with elongated morphology in human GBM compatible with kinaptic dynamics.

Options: View larger image (or click on image) Download as PowerPoint
Presence of T cells with elongated morphology in human GBM compatible wi...
(A) Representative confocal scanning of tumorigenic parenchyma from a human GBM biopsy. Infiltrated T cells marked with CD3 (green) populating tumor areas identified by the presence of highly reactive GFAP+ cells (magenta). Counterstaining with DAPI (blue) is shown for nuclei identification and to illustrate the hypercellularity of the area. The MERGE channel is also depicted. (B) Examples of T cells with elongated shape captured from the scan represented in A. The top panel shows the maximum intensity projection of the scanned tissue block, whereas the bottom panel shows a 3-D reconstruction of the same cells. Morphometric analyses of T cells populating GFAP-rich glioma areas (GFAPa) (C) in comparison with MHCII-rich stromal areas (MHCIIa) (D) revealed significant elongation of cells in the former, meaning that even though the size of T cells revealed no significant changes between the 2 tumor locations (E), T cells appear significantly elongated in tumorigenic areas (GFAPa) in comparison with stromal areas (MHCIIa) (F). Scale bars: 20 μm. **P < 0.01 and ***P < 0.001, Student t test and Mann-Whitney U test.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts